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Summary
Background: Oxidative stress as well as inﬂammation plays a pivotal role in the
pathogenesis of atherosclerosis. Although, various anti-oxidative dietary supple-
ments have been evaluated for their ability to prevent atherosclerosis, no effective
ones have been determined at present. ‘‘Camu-camu’’ (Myrciaria dubia) is an Ama-
zonian fruit that offers high vitamin C content. However, its anti-oxidative property
has not been evaluated in vivo in humans.
Methods: To assess the anti-oxidative and anti-inﬂammatory properties of camu-
camu in humans, 20 male smoking volunteers, considered to have an accelerated
oxidative stress state, were recruited and randomly assigned to take daily 70ml of
100% camu-camu juice, corresponding to 1050mg of vitamin C (camu-camu group;
n = 10) or 1050mg of vitamin C tablets (vitamin C group; n = 10) for 7 days.
Results: After 7 days, oxidative stress markers such as the levels of urinary
8-hydroxy-deoxyguanosine (P < 0.05) and total reactive oxygen species (P < 0.01)
and inﬂammatory markers such as serum levels of high sensitivity C reactive
protein (P < 0.05), interleukin (IL)-6 (P < 0.05), and IL-8 (P < 0.01) decreased sig-
niﬁcantly in the camu-camu group, while there was no change in the vitamin C
group.
Conclusions: Our results suggest that camu-camu juice may have powerful
anti-oxidative and anti-inﬂammatory properties, compared to vitamin C tablets
containing equivalent vitamin C content. These effects may be due to the exis-
tence of unknown anti-oxidant substances besides vitamin C or unknown substances
modulating in vivo vitamin C kinetics in camu-camu.
© 2008 Published by Elsevier Ireland Ltd on behalf of Japanese College of Cardiology.
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Introduction
Accumulating evidence has demonstrated that
oxidative stress (i.e., dysregulation of the cellular
redox state) and inﬂammation play a pivotal role
in the pathogenesis of atherosclerosis interacting
with each other. Although, various anti-oxidative
dietary supplements have been evaluated for their
ability to prevent atherosclerosis, no effective ones
have been determined at present. Vitamin C is
not only the most important dietary anti-oxidant
[1,2], but is also suggested to be a potent anti-
inﬂammatory agent [3—5]. Several studies have
found that dietary vitamin C or plasma vitamin
C was associated with a protective effect against
coronary artery disease [6—9].
‘‘Camu-camu’’ is an Amazonian fruit that offers
high vitamin C content ranging from 9 to 50 g/kg,
which is twofold that of acelora [10]. Additionally,
in vitro anti-oxidant activity of 100% camu-camu
juice evaluated by DPPH method reaches 50-fold
of that of 100% acelora juice (unpublished data),
suggesting its potentiality as an effective dietary
supplement to prevent atherosclerotic disease.
However, the anti-oxidative property has not been
evaluated in an in vivo human study. Furthermore,
the effects of camu-camu on inﬂammation have not
been elucidated.
This study was designed to establish the anti-
oxidative and anti-inﬂammatory properties of
camu-camu in vivo in humans.
Methods
Study design
Study subjects included 20 healthy male volun-
teers, all of whom were habitual smokers, being
considered to have an accelerated oxidative stress
state. All of the participants had neither his-
tory of atherosclerotic diseases such as coronary
artery disease or cerebrovascular disease nor risk
factors such as hypertension, diabetes, or hyperlipi-
demia except smoking habit by the annual physical
checkup. The participants were randomly assigned
to take daily 1050mg of vitamin C tablets (vitamin
C group; n = 10) or 70ml of 100% camu-camu juice,
containing 1050mg of vitamin C (camu-camu group;
n = 10) as a dietary supplement for 7 days, and to
continued smoking. The dose of 1050mg/day of
vitamin C in both groups was decided, based on pre-
vious studies [11—16]. In all subjects, 10ml of urine
and 15ml of peripheral blood were sampled at base-
line before intake of these dietary supplements, 7
days after the intake, and 1 month after ceasing
S
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he intake as at a washout stage. The blood sam-
les were immediately centrifuged at 1500× g for
5min at room temperature. The urine and serum
ere frozen and stored at −80 ◦C until analyzed.
e measured urine 8-hydroxy-deoxyguanosine (8-
HdG) levels and serum total reactive oxygen
pecies (ROS) levels as oxidative stress markers,
nd high sensitivity C-reactive protein (hsCRP) and
ultiple-cytokine levels as inﬂammatory markers.
he local institutional review board approved the
tudy protocol, and written informed consent was
btained from each participant.
aseline characteristics
rior to starting the intake of camu-camu or vitamin
, each participant was interviewed with regard
o brand of the cigarette and daily number of
igarettes consumed and daily intake of tar and
icotine was calculated as the content of tar or
icotine for each cigarette brand×daily number of
igarettes consumed. Blood pressure was measured
o the nearest 2mmHg in the same arm at base-
ine, using a mercury sphygmomanometer with an
ppropriately sized cuff.
easurements
rinary 8-OHdG levels were determined by compet-
tive enzyme-linked immunosorbent assay (ELISA)
sing the commercially available kit (8-OHdG
heck, Japan Institute for the Council of Aging,
ukuroi, Japan) [17]. Serum levels of total ROS
ere measured using a DEPPD reaction method by
ayashi et al. [18] applying the Fenton reaction on
multi-well plate. The hsCRP levels were measured
y particle-enhanced technology on the Behring BN
I nephrometer (Dade Behring Inc., Newark, DE,
SA) [19]. This assay used monoclonal anti-CRP
ntibodies and a calibrator that was also traceable
o World Health Organization reference materials.
he Luminex micro-beads array systemwas used for
multiplex assay of simultaneous quantiﬁcation of
he following 10 cytokines: interleukin (IL)-1, IL-2,
L-4, IL-5, IL-6, IL-8, IL-10, tumor necrosis factor-,
ranulocyte-macrophage colony stimulating factor,
nd -interferon. The assay was conducted as per
he manufacturer’s instructions (Luminex Corp.,
ustin, TX, USA), using a commercially available kit
BioSource International, Inc., Camarillo, CA, USA)
20].tatistical analysis
alues are expressed as the mean± S.D. for
arametric data, and median values and interquar-
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Table 1 Baseline characteristics
Vitamin C
(n = 10)
Camu-camu
(n = 10)
Age (year) 36 ± 4 37 ± 8
Height (cm) 171 ± 4 170 ± 5
Weight (kg) 72 ± 10 69 ± 15
Body mass index
(kg/m2)
25 ± 3 24 ± 5
Number of cigarette
(/day)
24 ± 8 21 ± 9
Tar intake (mg/day) 117 ± 93 143 ± 110
Nicotine intake
(mg/day)
10 ± 8 13 ± 10
Systolic blood
pressure (mmHg)
124 ± 8 123 ± 9
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pressure (mmHg)
79 ± 11 77 ± 5
ile ranges for non-parametric data. Intergroup
omparisons were performed using unpaired t-
ests for parametric data and Mann—Whitney’s U
ests for non-parametric data. Intragroup compar-
sons for non-parametric data were assessed using
ilcoxon Rank Sum tests. Correlations between two
ariables were assessed using Spearman rank cor-
elation coefﬁcient. P < 0.05 was considered to be
igniﬁcant.
esults
aseline characteristics such as the number of
igarettes consumed, daily intake of tar and nico-
ine, and systolic and diastolic blood pressure were
imilar in the two groups (Table 1). Overall, at
aseline before taking the dietary supplements,
rinary 8-OHdG levels (R = 0.47, P < 0.05), but not
erum levels of total ROS (R = 0.15, NS) were corre-
ated with the number of cigarettes (Fig. 1). Among
0 cytokines measured, the levels of 8 cytokines
T
s
l
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igure 1 Relationship between baseline levels of oxidative
rinary 8-OHdG levels were correlated with the number of ci129
except IL-6 and IL-8) were under the detection
imit in almost all subjects, and therefore, were
xcluded from the analysis. The baseline levels of
sCRP (R = 0.32, NS), IL-6 (R = 0.07, NS), and IL-8
R = 0.12, NS) were not correlated with the number
f daily cigarettes consumed.
In the camu-camu group, 8-OHdG levels (9.0
4.0, 21.2] to 7.0 [4.6, 14.6] ng/mg ·Cr, P < 0.05)
nd total ROS levels (128 [116,192] to 123 [110,162]
nit, P < 0.01) signiﬁcantly decreased 7 days after
aking the dietary supplements, and were restored
t the washout stage (to 11.2 [4.9, 20.9] ng/mgCr
n 8-OHdG, P < 0.05 and to 131 [121, 188] Unit in
otal ROS, P < 0.01). In the vitamin C group, how-
ver, both levels did not change (8.5 [4.1, 22.3], 8.7
3.0, 20.2], 10.5 [7.5, 14.3] ng/mgCr in 8-OHdG and
35 [88, 162], 134 [106, 156], 136 [113, 167] Unit
n total ROS) (Fig. 2).
In the camu-camu group, the levels of hsCRP
0.05 [0.01, 0.62] to 0.02 [0.01, 0.32]mg/dl,
< 0.05), IL-6 (6.0 [4.9, 6.9] to 5.1 [4.2, 6.4] pg/ml,
< 0.05), and IL-8 (24.8 [22.8, 30.6] to 22.4 [21.6,
4.5] pg/ml, P < 0.01) also signiﬁcantly decreased 7
ays after taking the dietary supplements. The lev-
ls were restored at the washout stage for hsCRP (to
.05 [0.01, 0.58]mg/dl, P < 0.05) and IL-8 (to 25.4
23.8, 27.9] pg/ml, P < 0.01), but did not for IL-6 (to
.3 [4.9, 10.8] pg/ml). In the vitamin C group, how-
ver, each level did not change (0.03 [0.01, 0.22],
.06 [0.01, 0.68], 0.05 [0.01, 0.13]mg/dl for hsCRP,
.3 [4.8, 7.3], 5.1 [4.4, 7.6], 5.5 [4.5, 7.8] pg/ml for
L-6 and 27.3 [24.9, 32.8], 25.1 [23.0, 31.6], 26.4
24.8, 33.4] pg/ml for IL-8) (Fig. 3).
iscussionhemajor ﬁnding of this study is that both oxidative
tress markers, urinary 8-OHdG and serum total ROS
evels, and inﬂammatory markers, hsCRP, IL-6 and
L-8, decreased 7 days after taking daily 70ml of the
stress markers and the number of cigarettes consumed.
garettes (left), but total ROS levels were not (right).
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Figure 2 Serial changes in the levels of oxidative stress markers. In the camu-camu group, both levels of urinary
ays
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l8-OHdG and serum total ROS signiﬁcantly decreased 7 d
washout stage of 1 month after cease of intake. In the
line represents median value, box represents interquarti
100% camu-camu juice, including 1050mg of the
vitamin C. The levels of these markers except IL-6
were restored at the washout stage of 1 month after
ceasing camu-camu intake. However, these changes
were not seen after intake of daily 1050mg of vita-
min C tablets in similar subjects. These results sug-
gest that camu-camu juice has more powerful anti-
oxidative and anti-inﬂammatory activities, com-
pared to vitamin C tablets, although the contents of
vitamin C are equivalent. In this study, we enrolled
male volunteers who were smokers but with neither
atherosclerotic disease nor other risk factors so that
we aimed to evaluate the anti-oxidant and anti-
p
r
c
b
Figure 3 Serial changes in the levels of inﬂammatory mark
and IL-8 signiﬁcantly decreased 7 days after taking the supp
month after cease of intake in hsCRP and IL-8. In the vitamin
represents median value, box represents interquartile rangeafter taking the supplement, and were restored at the
in C group, however, both levels did not change. Solid
nge, and error bar represents 95% conﬁdence interval.
nﬂammatory effects of camu-camu using subjects
ith accelerated oxidative stress independently of
ther risk factors. Our result of correlation between
aseline urinary 8-OHdG levels and the number of
aily cigarettes consumed may suggest the validity
f subject selection.
Atherosclerosis is characterized by the response
f the vessel wall to chronic multifactorial injury
eading to the formation of atheromatous or ﬁbrous
laques. Following vascular endothelial dysfunction
epresentative of an initial stage, smooth mus-
le dysfunction, metabolic abnormalities such as
reakdown of neurohormonal balance occur in var-
ers. In the camu-camu group, the levels of hsCRP, IL-6,
lement, and were restored at the washout stage of 1
C group, however, each level did not change. Solid line
and error bar represents 95% conﬁdence interval.
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ous stages of the atherosclerotic process. In this
equence of the atherosclerotiuc process, oxida-
ive stress and inﬂammation play an essential role
nteracting with each other [21,22]. It is well
ccepted that vitamin C has anti-oxidant effects
ith respect to scavenging both ROS and reac-
ive nitrogen species [1,2]. The Dietary Reference
ntake Panel of the US Institute of Medicine recom-
ends a vitamin C dietary allowance of 90mg/day
or men and 75mg/day for women [23]. This rec-
mmendation was based on many lines of evidence,
ncluding the amount required to maintain near-
aximum neutrophil concentrations with minimal
rinary excretion of ascorbate. A higher intake of
ruit and vegetables [24,25] as well as vitamin C
upplements [26] has been demonstrated to pre-
ent cardiovascular disease. In particular, higher
ntake of vitamin C is shown to be associated with
decreased risk of coronary artery disease in a
opulation with a high prevalence of smoking [27].
n contrast, Lee et al. [28] reported that supple-
ental vitamin C increased cardiovascular disease
isk in postmenopausal women with diabetes. They
onsidered that this contradictory result might be
aused by the fact that vitamin C can also act as a
ro-oxidant under certain circumstances [2,29,30].
t may also possibly explain our result that nei-
her urinary 8-OHdG levels nor serum total ROS
evels decreased after intake of 1050mg vitamin C
ablets. On the other hand, the anti-inﬂammatory
ffects of vitamin C are controversial. Vitamin C
as been shown to inhibit the LPS-induced number
f monocytes producing IL-6 and TNF- [4]. Another
n vitro study using the human endothelial cell line
CV 304 and HUVECS demonstrated that vitamin C
nhibited nuclear factor B, a central mediator of
ltered gene expression during inﬂammation [5].
n humans, daily intake of 1500mg vitamin C sup-
lement in runners attenuated an increase in IL-1
eceptor antagonist, IL-6, IL-10, and IL-8 follow-
ng 90 km ultramarathon [11]. In a cross-sectional
nalysis of the third US National Health and Nutri-
ion Examination Survey data, Ford et al. [31]
eported that plasma CRP levels were inversely and
igniﬁcantly associated with concentration of vita-
in C after adjustment for age, sex, race-ethnity,
ducation, body mass index, leisure-time physical
ctivity, and aspirin use. In addition, Wannamethee
t al. [32] reported a signiﬁcant inverse associa-
ion of dietary and plasma vitamin C and fruit and
egetable intakes with biomarkers of inﬂammation
n a cross-sectional study of 3258 men aged 60—69
ears who had no history of cardiovascular disease
r diabetes. However, a review of the prospective
tudies to date found that 4 of the 5 studies with
oses ranging from daily 250 to 3000mg vitamin131
in persons with diabetes, hypercholesterolemia,
emodialysis, or coronary artery disease reported
o anti-inﬂammatory effects [12—16], correspond-
ng to our results that 1050mg vitamin C tablets did
ot decrease the inﬂammatory markers.
Because of its particularly high vitamin C con-
ent, camu-camu is considered to have high
utritional value. Our study provides the ﬁrst in
ivo human data demonstrating the anti-oxidative
nd anti-inﬂammatory effects of camu-camu juice.
oreover, the effects of camu-camu were more
owerful, compared with those of vitamin C
ablets, despite the equivalent vitamin C contents.
n this respect, there are two possible mecha-
isms. First, camu-camu possibly contains other
nti-oxidative substances besides vitamin C. In
ddition to high contents of vitamin C, camu-camu
ontains carotenoids [33] and anthocyanines [34]
s potential anti-oxidants. Otherwise, there may
e other unknown contents potentially acting as
nti-oxidative and/or anti-inﬂammatory substances
n camu-camu. Second, camu-camu may have sub-
tances that increase in vivo availability of vitamin
such as by absorption or excretion. Camu-camu
lso contains high levels of potassium [35], which
s considered to accelerate intestinal absorption
f vitamin C [36]. To elucidate these mechanistic
ssues, the efforts such as search for anti-oxidative
r anti-inﬂammatory substance, or comparison of in
ivo vitamin C kinetics between camu-camu juice
nd vitamin C supplement would be required.
Although the mechanisms are not clear, camu-
amu juice has more powerful anti-oxidative and
nti-inﬂammatory properties, compared to vitamin
tablets containing equivalent vitamin C contents,
nd thus may be expected as a dietary supplement
o prevent atherosclerosis.
cknowledgments
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